PLoS ONE (Jan 2022)

Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression.

  • Haremaru Kubo,
  • Yuya Tsurutani,
  • Kosuke Inoue,
  • Kazuki Watanabe,
  • Yuto Yamazaki,
  • Takashi Sunouchi,
  • Yoshitomo Hoshino,
  • Rei Hirose,
  • Sho Katsuragawa,
  • Hiromitsu Tannai,
  • Yukiko Shibahara,
  • Yukio Kakuta,
  • Seishi Matsui,
  • Jun Saito,
  • Masao Omura,
  • Hironobu Sasano,
  • Tetsuo Nishikawa

DOI
https://doi.org/10.1371/journal.pone.0267732
Journal volume & issue
Vol. 17, no. 4
p. e0267732

Abstract

Read online

Primary aldosteronism (PA) usually accompanies suppressed plasma renin activity (PRA) through a negative feedback mechanism. While some cases of PA with unsuppressed PRA were reported, there have been no studies about the characteristics of PA with unsuppressed PRA; thus, these characteristics were examined herein. Nine patients with unsuppressed PRA and 86 patients with suppressed PRA were examined. All patients underwent segmental adrenal venous sampling (sAVS) and adrenalectomy, and were pathologically confirmed to have cytochrome P450 11B2 (CYP11B2)-positive aldosterone-producing adenoma according to international histopathology consensus criteria. Unsuppressed and suppressed PRA were defined as PRA levels of > 1.0 and ≤ 1.0 ng/mL/hr, respectively, in multiple blood samples obtained in the resting position. The unsuppressed PRA group had higher morning cortisol levels (12.6 [8.5, 13.5] vs. 8.5 [7.1, 11.0] μg/dL, P = 0.03) and higher cortisol levels after a 1 mg dexamethasone suppression test (DST) (2.2 [1.6, 2.5] vs. 1.3 [1.0, 1.9] μ g/dL, P = 0.004) than the suppressed PRA group. The unsuppressed PRA group also showed higher aldosterone levels on the non-surgical side during sAVS (P = 0.02 before adrenocorticotropic hormone (ACTH) stimulation, P = 0.002 after ACTH stimulation), a higher intensity of CYP17 expression in the resected adrenal gland (P = 0.02), and a lower clinical complete success rate 1 year after surgery (P = 0.04) compared with those in the suppressed PRA group. These findings suggest that PA should not be ruled out by unsuppressed PRA among patients with hypertension, particularly when their cortisol levels remain unsuppressed in the 1 mg DST. Meanwhile, it should be acknowledged that patients with unsuppressed PRA have higher aldosterone levels on the non-surgical side, and a lower likelihood of postoperative complete clinical success is to be expected.